The anorexiants industry will relinquish an approximated estimate at a frequency of 3.5% for the projection space of 2020 to 2027 with factors such as rising prevalence of obesity and rise in geriatric population. Surge in lifestyle disorders also acts as a major factor for the growth of the anorexiants market. Increasing level of stress has also given a boom to the U.S. anorexiants market.
Increasing research and developmental activities has propelled the demand of the anorexiants market. However, the adoption of alternative treatments and recall of drugs have decreased the demand of the anorexiants market.
The U.S. Anorexiants Market Scenario
According to Data Bridge Market Research, the market for anorexiants has the market leader namely, VIVUS Inc., which accounts an estimated market share of approximately 17.59% in the U.S. anorexiants market. The company has gained outstanding sale by providing advanced anorexiants.
- In January 2020, VIVUS Inc. has achieved positive result from clinical trial of Qsymia in adults’ patients. These results demonstrated the efficacy of Qsymia and paved the way for the company to achieve more product sales by allowing its product usage for wide applications among different age groups.
Trends Impacting the Anorexiants Market
Now the question is which are the other regions that VIVUS Inc., Currax Pharmaceuticals LLC. and Mylan N.V. are targeting?
The U.S. anorexiants market is becoming more competitive with companies such as VIVUS Inc., Currax Pharmaceuticals LLC. and Mylan N.V. These are the top dominating companies in anorexiants market and are launching more new drugs in the anorexiants market. The Data Bridge Market Research new reports highlight the major growth factors and opportunities in the U.S. anorexiants market.
For more analysis on the U.S. anorexiants market request for a briefing with our analysts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=us-anorexiants-market
Anorexiants Market Developments
- In November 2019, Mylan N.V. and Pfizer Inc. have established a new company Viatris, which will signify the strength of these companies. This expansion helped the company to accelerate the business growth involving anorexiants drug sales.
- In September 2019, Currax Pharmaceuticals LLC. acquired Nalpropion Pharmaceuticals, a company engaged in manufacturing of CONTRAVE, an anorexiants used for obesity treatment. This acquisition helped the company to expand its footprint in the U.S. anorexiants market.
Scope of the U.S. Anorexiants Market
All country based analysis of the U.S. anorexiants market is further analysed based on maximum granularity into further segmentation. On the basis of drug class, the anorexiants market is segmented into catecholamines anorexiants and serotonin anorexiants. On the basis of drug type, the anorexiants market is segmented into generics and branded. On the basis of applications, the anorexiants market is segmented into weight loss, obesity, attention deficit hyperactivity disorder (ADHD), and dravet syndrome. On the basis of prescription mode, the anorexiants market is segmented into prescription and OTC. On the basis of route of administration, the anorexiants market is segmented into oral and parenteral. On the basis of end user, the anorexiants market is segmented into hospitals, specialty clinics, and home healthcare. On the basis of distribution channel, the anorexiants market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies.
To know more about the study https://www.databridgemarketresearch.com/reports/us-anorexiants-market
Key Pointers Covered in the U.S. Anorexiants Market Industry Trends and Forecast to 2027
- Market Size
- Top to Bottom Market Analysis
- Recent Developments for Market Competitors
- Recent Market Value for Different Countries
- Market Value and Over View of Anorexiants Market
- Company Profiling of Top Eight Players of Anorexiants Market
Key Market Competitors Covered in the Report
- VIVUS Inc.
- KVK Tech, Inc.
- Currax Pharmaceuticals LLC.
- Recordati Rare Diseases (a subsidiary of RECORDATI S.p.A.)
- Aurobindo Pharma USA (a subsidiary of Aurobindo Pharma)
- Sun Pharmaceutical Industries Ltd.
- Pfizer Inc.
- Teva Pharmaceutical USA Inc. (a subsidiary of Teva Pharmaceutical Industries Ltd.)
- sanofi-aventis U.S. LLC (A Subsidiary of Sanofi)
- Hikma Pharmaceuticals PLC
- Lannett
- Zydus Pharmaceuticals, Inc. (a subsidiary of Zydus Cadila)
- Dr. Reddy’s Laboratories Ltd.
- Sandoz AG (a business division of Novartis AG)
- Mylan N.V.
- Bausch Health Companies Inc.
- Cipla Inc.
- Par Pharmaceutical (a subsidiary of Endo International plc)
- Amphastar Pharmaceuticals, Inc.
Above are the key players covered in the report, to know about more and exhaustive list of anorexiants companies’, contact us https://www.databridgemarketresearch.com/toc/?dbmr=us-anorexiants-market
Research Methodology: The U.S. Anorexiants Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Primary Respondents
- Demand Side: Manufacturers, Healthcare Industries, Bariatric Surgeons, Scientists, Research Laboratories
- Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.
Related Reports
- Global Weight Management Market – Industry Trends and Forecast to 2026
- Global Weight Loss and Obesity Management Market – Industry Trends and Forecast to 2026
Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/
